10/16/2019 | Press release | Archived content
For Immediate Release: October 16, 2019
513-579-9911 x 12627
CINCINNATI, OH - (October 16, 2019) - Medpace (MEDP) a scientifically-driven, global full-service clinical research organization (CRO), announced that Dr. Ajay Srivastava, Medpace Medical Director in Nephrology, will be presenting during a session at the DEVENIR Foundation's 6th Education Forum for Nephrologists in Quebec. Details about his presentation follow:
Title: Principles of Fluid Management & 'Kidney Safe' Considerations
When: 19 October 2019
Objectives of the presentation include:
Dr. Ajay Srivastava is a board-certified nephrologist with an extensive background in both clinical and academic medicine, who has lectured at the local, regional, and national levels. Specializing in adult nephrology, he brings over 12 years of experience in both the common and rare conditions of the kidney, renal replacement therapies, ICU nephrology including IV fluid resuscitation and management, and comorbid conditions such as cardiorenal syndrome and hypertension. As an interventional nephrologist, he provided education, assistance, and evaluation regarding matters of dialysis vascular access including the performance of interventional procedures to preserve, optimize, and salvage these hemodialysis accesses. Most recently, he served as the Director of the Nephrology Fellowship Program at the University of Cincinnati College of Medicine where he was responsible for the education and training of future nephrologists. Dr. Srivastava has also held several other leadership positions including the Medical Directorship of dialysis facilities, Division Chief of Nephrology, and Interim Chair of Medicine, and has served on a number of departmental, hospital, and university committees.
Dr. Srivastava graduated with honors from the University of Rochester with a Bachelor of Arts in Psychology and subsequently earned his medical degree from the University of Texas Medical Branch. His postgraduate training was completed at the University of Rochester Medical Center and includes his residency in Internal Medicine and his fellowship in Nephrology. He holds board certifications in both Nephrology and Internal Medicine.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.